Related Experiment Video

Updated: Jul 30, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

Question 5: Magnesium Sulphate for Acute Asthma in children

R Aniapravan1, A Pullattayil2, K Al Ansari3

  • 1Sidra Medicine, P O Box 26999, Doha, Qatar; Weill Cornell Medical College, Doha, Qatar.

Paediatric Respiratory Reviews
|July 1, 2020
PubMed

Insights

Magnesium sulfate (MgSO4) is increasingly used for severe childhood asthma when initial treatments fail. This review synthesizes evidence on its use and potential mechanisms in acute pediatric asthma management.

Area of Science:

  • Pediatric Emergency Medicine
  • Respiratory Medicine
  • Pharmacology

Background:

  • Standard acute asthma treatment in children includes inhaled beta-agonists, oxygen, and systemic steroids.
  • Evidence for secondary treatment options in severe pediatric asthma attacks is less defined.
  • Intravenous magnesium sulfate (MgSO4) is frequently used, with nebulized forms emerging in initial therapy.

Purpose of the Study:

  • To examine the role of magnesium sulfate (MgSO4) in acute asthma management in children.
  • To explore the potential mechanisms of action for MgSO4 in pediatric asthma.
  • To review current recommendations and evidence supporting MgSO4 use.

Main Methods:

  • Literature review of studies on magnesium sulfate in acute pediatric asthma.
  • Analysis of evidence for both nebulized and intravenous administration of MgSO4.
  • Synthesis of current clinical recommendations and research findings.

Main Results:

  • Discusses the potential physiological effects of MgSO4 in bronchodilation and reducing airway inflammation.
  • Presents evidence supporting the efficacy of both intravenous and nebulized MgSO4 in specific pediatric asthma cohorts.
  • Highlights variability in current treatment guidelines and practice.

Conclusions:

  • Magnesium sulfate represents a valuable option for severe acute asthma in children unresponsive to initial therapies.
  • Further research is needed to clarify optimal dosing, administration routes, and long-term effects.
  • Standardizing the use of MgSO4 in pediatric asthma protocols requires robust evidence.

Keywords:
Magnesium sulphatePharmacologySevere asthma attacks

More Related Videos

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Conducting Respiratory Oscillometry in an Outpatient Setting14:49

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: